重庆时时app下载

Overview

Contact us

Overview

重庆时时app下载Founded in May 2015, Sanyou Biopharmaceuticals Co., Ltd. is a leading high-throughput research and development company for innovative antibody drugs.

Sanyou Bio has established a fully functional laboratory in Shanghai Caohejing High-tech Park, with advanced facilities and equipment on a site of more than 3000 m2. Sanyou Bio has developed and validated more than 20 state-of-art antibody discovery platforms, such as “sub-Trillion Human Naïve Antibody Library”, “sub-Trillion Single Domain Antibody Library”, stable expressing cell line and small-scale process development platforms. Sanyou Bio has provided world-class innovative antibody drug research services including integrated antibody discovery and validation, staged technical service and PCC antibody license-out.

重庆时时app下载Sanyou Bio was founded by experienced professionals from international and domestic antibody drug companies who have comprehensive experience and insight in innovative antibody drug discovery, IND application and clinical trial management. The company has built a strong executive team of more than 90 staffs mainly comprised of competent doctor and master degree holders.

Up to July 2019, Sanyou Bio has served more than 70 domestic and international pharmaceutical and biotechnology companies, and more than 80% of the customers seek for further collaborations.

Core business

Sanyou bio focuses on the early stage of research and development of the discovery of antibody drug, from "antigen and antibody production" to "animal pharmacodynamic screening", and provides integrated antibody drug development services. Our core business includes internationally advanced and domestically leading technology sub-platforms, such as "integrated protein expression and antigen preparation", "diversified antibody production", "innovative antibody engineering", "systematic antibody drug functional screening", "high-efficiency antibody drugability evaluation", "large-capacity phage display fully human antibody library", "integrated innovative monoclonal antibody drug discovery" can meet the various needs of early development of antibody drugs.

Platform overview

Focusing on the key stages of early discovery of antibody drugs, Sanyou bio is committed to establishing Chinese leading and world-class innovative antibody research and development and project incubation platforms. At present, six core technology platforms and five additional technology platforms have been established, and we have provided four types of high-tech technical services of "systematization and large-scale" based on these platforms.

Team introduction

Sanyou is committed to establishing Chinese leading and world-class innovative antibody research and development and project incubation platforms. Based on these platforms, we launch internationally competitive technical services and projects.

Sanyou bio has a highly educated, high-quality core team. As an innovative enterprise with antibody research and development as its core, Sanyou Bio has gathered outstanding talents from the world. They have worked together and witnessed the rapid development of Sanyou bio and the gradual realization of its great dreams. Team members are young and energetic, innovative and brave enough to face with challenges.

重庆时时app下载In 2017, in the “Over 100 Billion Antibody Library” cooperation plan, the technical team will continue to make use of our own advantages and construct a world-leading antibody library to help scientific research and benefit the society.

Our antibody technology team works for the company's antibody customization and antibody library development. The team members have many years of experience in antibody technology research and development. Since its establishment, hundreds of related services have been successfully delivered.

Our team are good at innovation, have courage to challenge difficulties, and never give up while focusing on each goal. The first-class technical ability and innovative spirit ensure the rapid development of the company's antibody library research and development.

Sufficient equipment

重庆时时app下载The company has more than 140 instruments including AKTA, HPLC, flow cytometer, Fortebio protein interaction analyzer, magnetic bead high-throughput screening system, multi-function microplate reader, micro-organism and mammalian cell electro-transfection instrument and other international first-class instruments and equipment. It covers all kinds of instruments and equipment needed for molecular biology, protein expression and purification, cell strain construction, antibody drug functional screening, antibody engineering and antibody physicochemical analysis.

Social honor

Sanyou is committed to establishing Chinese leading and world-class innovative antibody research and development and project incubation platforms. Based on these platforms, we launch internationally competitive technical services and projects.